Interleukin-23 subunit alpha — Drug Target

All drugs that target Interleukin-23 subunit alpha — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Interleukin-23 Antagonist [EPC]

Marketed (3)

• Skyrizi · AbbVie · Interleukin-23 Antagonist [EPC] · Immunology
  Skyrizi works by blocking the interleukin-23 protein, which plays a key role in inflammation and immune response.
• Omvoh · Eli Lilly Nederland B.V. · Interleukin-23 Antagonist [EPC] · Immunology
  MIRIKIZUMAB blocks the activity of Interleukin-23, a protein involved in inflammation.
• OMVOH · ELI LILLY AND CO · Interleukin-23 Antagonist [EPC] · Immunology